Early Exanthema Upon Vemurafenib Plus Cobimetinib Is Associated With a Favorable Treatment Outcome in Metastatic Melanoma: A Retrospective Multicenter DeCOG Study

to connected objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
Online-Ressource
Language
Englisch

Bibliographic citation
In: Frontiers in Oncology 11 (2021): 672172.

Event
Veröffentlichung
(where)
Erlangen
(who)
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
(when)
2021
Creator
Kähler, Katharina C.
Gutzmer, Ralf
Meier, Friedegrund
Zimmer, Lisa
Heppt, Markus
Gesierich, Anja
Thoms, Kai-Martin
Utikal, Jochen
Hassel, Jessica C.
Loquai, Carmen
Pföhler, Claudia
Heinzerling, Lucie
Kaatz, Martin
Göppner, Daniela
Pflugfelder, Annette
Bohne, Ann-Sophie
Satzger, Imke
Reinhardt, Lydia
Placke, Jan-Malte
Schadendorf, Dirk
Ugurel, Selma

DOI
10.3389/fonc.2021.672172
URN
urn:nbn:de:bvb:29-opus4-165333
Rights
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
25.03.2025, 1:43 PM CET

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Kähler, Katharina C.
  • Gutzmer, Ralf
  • Meier, Friedegrund
  • Zimmer, Lisa
  • Heppt, Markus
  • Gesierich, Anja
  • Thoms, Kai-Martin
  • Utikal, Jochen
  • Hassel, Jessica C.
  • Loquai, Carmen
  • Pföhler, Claudia
  • Heinzerling, Lucie
  • Kaatz, Martin
  • Göppner, Daniela
  • Pflugfelder, Annette
  • Bohne, Ann-Sophie
  • Satzger, Imke
  • Reinhardt, Lydia
  • Placke, Jan-Malte
  • Schadendorf, Dirk
  • Ugurel, Selma
  • Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)

Time of origin

  • 2021

Other Objects (12)

Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study

Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study

Discontinuation of BRAF/MEK-directed targeted therapy after complete remission of metastatic melanoma — a retrospective multicenter ADOReg study

Discontinuation of BRAF/MEK-directed targeted therapy after complete remission of metastatic melanoma — a retrospective multicenter ADOReg study

Efficacy of Vinflunine for Patients with Metastatic Urothelial Cancer after Immune Checkpoint Inhibitor Pretreatment—A Retrospective Multicenter Analysis

Efficacy of Vinflunine for Patients with Metastatic Urothelial Cancer after Immune Checkpoint Inhibitor Pretreatment—A Retrospective Multicenter Analysis

Tolerability of BRAF and MEK Inhibitors for Metastasized Melanoma after Intra-Class Switch: A Multicenter, Retrospective Study

Tolerability of BRAF and MEK Inhibitors for Metastasized Melanoma after Intra-Class Switch: A Multicenter, Retrospective Study

Favorable

Illustration

Favorable

Clinical determinants of long-term survival in metastatic uveal melanoma

Clinical determinants of long-term survival in metastatic uveal melanoma

Antibody-Mediated Status Epilepticus: A Retrospective Multicenter Survey

Antibody-Mediated Status Epilepticus: A Retrospective Multicenter Survey

Response durability after cessation of immune checkpoint inhibitors in patients with metastatic Merkel cell carcinoma : a retrospective multicenter DeCOG study

Response durability after cessation of immune checkpoint inhibitors in patients with metastatic Merkel cell carcinoma : a retrospective multicenter DeCOG study

The efficacy of re-challenge with BRAF inhibitors after previous progression to BRAF inhibitors in melanoma : : a retrospective multicenter study

The efficacy of re-challenge with BRAF inhibitors after previous progression to BRAF inhibitors in melanoma : : a retrospective multicenter study

Immune checkpoint inhibitor triggered parkinsonism in a patient with metastatic melanoma

Immune checkpoint inhibitor triggered parkinsonism in a patient with metastatic melanoma

Contestación favorable

Abschnitt

Contestación favorable

Contestación favorable

Abschnitt

Contestación favorable

Related objects